Nontuberuclous mycobacterial disease: updated diagnostic criteria for an under-recognized infectious complication of anti-tumor necrosis factor therapy.
Winthrop
Kevin L
KL
Division of Infectious Diseases, Ophthalmology, and Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USA. winthrop@ohsu.edu
Daley
Charles L
CL
Griffith
David
D
D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000139:chemically induced* / Q000175:diagnosis* / Q000453:epidemiology; D014057:Tomography, X-Ray Computed; D014397:Tuberculosis, Pulmonary / Q000139:chemically induced / Q000175:diagnosis*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha